Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugs.
Viron
Béatrice
B
Association pour l'Utilisation du Rein Artificiel, France. beatrice.viron@auraparis.org
Dupuy
Claire-Antoinette
CA
Kolta
Amir
A
Casadevall
Nicole
N
D000369:Aged, 80 and over; D000068256:Darbepoetin alfa; D004351:Drug Resistance; D004921:Erythropoietin / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000276:immunology / Q000627:therapeutic use; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced* / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
D006397:Hematinics; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa